Specificity protein 1/3 regulate T-cell acute lymphoblastic leukemia cell proliferation and apoptosis through β-catenin by acting as targets of miR-495-3p
Annals of Hematology · 2024
DOI: 10.1007/s00277-024-05764-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Boyang Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Hematology clinic, Harbin Medical University Cancer Hospital, No.150 Haping Road, Nangang District, Harbin, 150081, China. Hauptthemen laut MEDLINE: Apoptosis, beta Catenin, Cell Proliferation, MicroRNAs. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hematology clinic, Harbin Medical University Cancer Hospital, No.150 Haping Road, Nangang District, Harbin, 150081, China.
- Department of Hematology, Hainan Cancer Hospital, Haikou, China.
- Hematology clinic, Harbin Medical University Cancer Hospital, No.150 Haping Road, Nangang District, Harbin, 150081, China. aichun2002@hotmail.com.
Zitieren
APA
Zheng, B., Geng, Y., Li, Y., Huang, H., & Liu, A. (2024). Specificity protein 1/3 regulate T-cell acute lymphoblastic leukemia cell proliferation and apoptosis through β-catenin by acting as targets of miR-495-3p. Annals of Hematology. https://doi.org/10.1007/s00277-024-05764-2
Vancouver
Zheng B, Geng Y, Li Y, Huang H, Liu A. Specificity protein 1/3 regulate T-cell acute lymphoblastic leukemia cell proliferation and apoptosis through β-catenin by acting as targets of miR-495-3p. Annals of Hematology. 2024. doi:10.1007/s00277-024-05764-2
BibTeX
@article{Zheng2024,
author = {Zheng, Boyang and Geng, Yueqi and Li, Yan and Huang, Huixiong and Liu, Aichun},
title = {Specificity protein 1/3 regulate T-cell acute lymphoblastic leukemia cell proliferation and apoptosis through β-catenin by acting as targets of miR-495-3p},
journal = {Annals of Hematology},
year = {2024},
doi = {10.1007/s00277-024-05764-2}
}
EUVIMED